The tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumors Meeting Abstract

  


Authors: Moasser, M. M.; Basso, A. D.; Averbuch, S. D.; Rosen, N.
Abstract Title: The tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumors
Meeting Title: 2001 AACR-NCI-EORTC International Conference - Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications
Journal Title: Clinical Cancer Research
Volume: 7
Issue: 11 Suppl.
Meeting Dates: 2001 Oct 29-Nov 2
Meeting Location: Miami Beach, FL
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2001-11-01
Start Page: 3769s
Language: English
ACCESSION: WOS:000172121800568
PROVIDER: wos
PUBMED: 11727717
Notes: Meeting Abstract: 576 -- Source: Wos
Citation Impact
What is Dimensions Citation Badge?
MSK Authors
  1. Andrea D. Basso
    32 Basso
  2. Mark M Moasser
    56 Moasser
  3. Neal Rosen
    425 Rosen
Related MSK Work